Patel Kinnari

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 84% 68% 82%
Transactions
12 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 72%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Patel Kinnari's trades of Rocket Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
29.84
Quantity 7,132
Value US$212,804
Transaction date
Proposed sale
Price
21.08
Quantity 1,148
Value US$24,204
Transaction date
Proposed sale
Price
15.47
Quantity 1,534
Value US$23,733
Transaction date
Proposed sale
Price
21.38
Quantity 1,330
Value US$28,429
Transaction date
Purchase
Price
9.50
Quantity 1,000 +17.6%
Value US$9,500
Transaction date
Purchase
Price
14.98
Quantity 5,675 +inf%
Value US$85,012
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-22 2025-05-20
S Sale
30,514 -48.0%
298.75
US$31,735 		30,514 -48.0% 298.75 US$31,735
2025-05-20 2025-05-20
PrS Proposed sale
82,748
301.85
US$2,678,117 		82,748 301.85 US$2,678,117
2025-05-20 2025-05-16
S Sale
46,430 +38.3%
70.23
US$251,394 		46,430 +38.3% 70.23 US$251,394
2025-05-16 2025-05-16
PrS Proposed sale
1,409
6.53
US$9,197 		1,409 6.53 US$9,197
2025-04-10 2025-04-09
B Purchase
21,099 +371.8%
4.70
US$99,165 		21,099 +371.8% 4.70 US$99,165
2025-02-25 2025-02-21
S Sale
6,078 -1.4%
10.58
US$64,305 		6,078 -1.4% 10.58 US$64,305
2025-02-21 2025-02-21
PrS Proposed sale
6,078
10.58
US$64,313 		6,078 10.58 US$64,313
2024-11-25 2024-11-21
S Sale
4,588 -1.2%
13.05
US$59,892 		4,588 -1.2% 13.05 US$59,892
2024-11-21 2024-11-21
PrS Proposed sale
4,588
13.05
US$59,892 		4,588 13.05 US$59,892
2024-08-20 2024-08-16
S Sale
3,989 -1.0%
18.50
US$73,812 		3,989 -1.0% 18.50 US$73,812
2024-08-16 2024-08-16
PrS Proposed sale
3,989
18.50
US$73,810 		3,989 18.50 US$73,810
2024-05-20 2024-05-16
S Sale
4,046 -1.0%
23.35
US$94,474 		4,046 -1.0% 23.35 US$94,474
2024-05-16 2024-05-16
PrS Proposed sale
4,046
23.35
US$94,489 		4,046 23.35 US$94,489
2024-02-21 2024-02-16
S Sale
7,132 -2.9%
29.84
US$212,805 		7,132 -2.9% 29.84 US$212,805
2024-02-16 2024-02-16
PrS Proposed sale
7,132
29.84
US$212,804 		7,132 29.84 US$212,804
2023-11-16 2023-11-16
PrS Proposed sale
1,148
21.08
US$24,204 		1,148 21.08 US$24,204
2023-08-21 2023-08-17
S Sale
1,534 -0.7%
15.47
US$23,733 		1,534 -0.7% 15.47 US$23,733
2023-08-17 2023-08-17
PrS Proposed sale
1,534
15.47
US$23,733 		1,534 15.47 US$23,733
2023-05-19 2023-05-17
S Sale
1,330 -0.6%
21.38
US$28,429 		1,330 -0.6% 21.38 US$28,429
2023-05-17 2023-05-17
PrS Proposed sale
1,330
21.38
US$28,429 		1,330 21.38 US$28,429
2020-12-30 2020-12-28
PlS Planned sale
5,427 -5.4%
57.17
US$310,238 		5,427 -5.4% 57.17 US$310,238
2020-12-30 2020-12-28
PlS Planned sale
11,334 -10.1%
56.51
US$640,507 		11,334 -10.1% 56.51 US$640,507
2020-03-19 2020-03-18
B Purchase
1,000 +17.6%
9.50
US$9,500 		1,000 +17.6% 9.50 US$9,500
2018-12-10 2018-12-06
B Purchase
5,675 +inf%
14.98
US$85,012 		5,675 +inf% 14.98 US$85,012